Lars Daniel Engstrom

Title: Lars Daniel Engstrom: Innovator in Cancer Treatment

Introduction

Lars Daniel Engstrom is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative combination therapies targeting KRas G12C cancers. With a total of 6 patents to his name, Engstrom continues to push the boundaries of medical science.

Latest Patents

Engstrom's latest patents focus on combination therapies for treating KRas G12C cancers. One of his notable inventions involves methods of treating cancer in subjects in need thereof. This includes administering a therapeutically effective amount of a combination of a SHP-2 inhibitor and a KRAS G12C inhibitor. Additionally, he has developed pharmaceutical compositions comprising effective amounts of these inhibitors, along with kits and methods for their use. Another patent also emphasizes the use of a pan ErbB family inhibitor in conjunction with a KRAS G12C inhibitor, showcasing his commitment to advancing cancer therapies.

Career Highlights

Engstrom is currently associated with Mirati Therapeutics, Inc., where he applies his expertise in developing innovative cancer treatments. His work has been instrumental in creating therapies that offer hope to patients battling difficult-to-treat cancers.

Collaborations

Engstrom collaborates with notable colleagues, including James Gail Christensen and Peter Olson. Their combined efforts contribute to the advancement of cancer research and treatment methodologies.

Conclusion

Lars Daniel Engstrom stands out as a key figure in the field of cancer treatment innovation. His dedication to developing effective therapies for KRas G12C cancers exemplifies the impact of inventors in the medical field.